Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal alkaline phosphatase (IAP) is an enzyme expressed in the small intestine by enterocytes. It plays a crucial role in maintaining intestinal homeostasis, protecting gut barrier integrity, and regulating interactions between diet, microbiota, and host immunity. Its primary functions include dephosphorylation of various substrates such as lipopolysaccharide (LPS), flagellin, CpG DNA, ATP/ADP, and other nucleotide di-/tri-phosphates. Deficiency is linked to several gastrointestinal disorders. IAP is also used in drug delivery for phosphate prodrug cleavage.
Phosphate prodrug cleavage on mucosal surfaces to release active drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Alkaline Phosphatase (IAP).